131 related articles for article (PubMed ID: 34705847)
21. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
[TBL] [Abstract][Full Text] [Related]
22. Copayments did not reduce medicaid enrollees' nonemergency use of emergency departments.
Mortensen K
Health Aff (Millwood); 2010 Sep; 29(9):1643-50. PubMed ID: 20820020
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
Stallworth JR; Jerrell JM; Tripathi A
Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
[TBL] [Abstract][Full Text] [Related]
24. Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017.
Mikosz CA; Zhang K; Haegerich T; Xu L; Losby JL; Greenspan A; Baldwin G; Dowell D
JAMA Netw Open; 2020 May; 3(5):e204514. PubMed ID: 32391892
[TBL] [Abstract][Full Text] [Related]
25. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
[TBL] [Abstract][Full Text] [Related]
26. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events.
Chandwani HS; Strassels SA; Rascati KL; Lawson KA; Wilson JP
J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):206-13. PubMed ID: 23879214
[TBL] [Abstract][Full Text] [Related]
27. Impact of Chronic Conditions on Emergency Department Visits of Children Using Medicaid.
Berry JG; Rodean J; Hall M; Alpern ER; Aronson PL; Freedman SB; Brousseau DC; Shah SS; Simon HK; Cohen E; Marin JR; Morse RB; O'Neill M; Neuman MI
J Pediatr; 2017 Mar; 182():267-274. PubMed ID: 27979584
[TBL] [Abstract][Full Text] [Related]
28. Health insurance status and the use of emergency and other outpatient services by adults with sickle cell disease.
Hand R; Koshy M; Dorn L; Patel M
Ann Emerg Med; 1995 Feb; 25(2):224-9. PubMed ID: 7832351
[TBL] [Abstract][Full Text] [Related]
29. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
Lubeck D; Agodoa I; Bhakta N; Danese M; Pappu K; Howard R; Gleeson M; Halperin M; Lanzkron S
JAMA Netw Open; 2019 Nov; 2(11):e1915374. PubMed ID: 31730182
[TBL] [Abstract][Full Text] [Related]
30. Use of Federally Qualified Health Centers and Potentially Preventable Hospital Utilization Among Older Medicare-Medicaid Enrollees.
Wright B; Potter AJ; Trivedi AN
J Ambul Care Manage; 2017; 40(2):139-149. PubMed ID: 27893515
[TBL] [Abstract][Full Text] [Related]
31. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
Liang D; Bao Y; Wallace M; Grant I; Shi Y
Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
[TBL] [Abstract][Full Text] [Related]
32. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
[TBL] [Abstract][Full Text] [Related]
33. Sickle cell disease-related pediatric medical expenditures in the U.S.
Amendah DD; Mvundura M; Kavanagh PL; Sprinz PG; Grosse SD
Am J Prev Med; 2010 Apr; 38(4 Suppl):S550-6. PubMed ID: 20331957
[TBL] [Abstract][Full Text] [Related]
34. The influence of health literacy on emergency department utilization and hospitalizations in adolescents with sickle cell disease.
Caldwell EP
Public Health Nurs; 2019 Nov; 36(6):765-771. PubMed ID: 31402511
[TBL] [Abstract][Full Text] [Related]
35. Medicaid managed care and preventable emergency department visits in the United States.
Toseef MU; Jensen GA; Tarraf W
PLoS One; 2020; 15(10):e0240603. PubMed ID: 33119642
[TBL] [Abstract][Full Text] [Related]
36. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients.
Brummett CM; Evans-Shields J; England C; Kong AM; Lew CR; Henriques C; Zimmerman NM; Sun EC
J Manag Care Spec Pharm; 2021 Jun; 27(6):760-771. PubMed ID: 33624534
[No Abstract] [Full Text] [Related]
37. Conversion to Persistent or High-Risk Opioid Use After a New Prescription From the Emergency Department: Evidence From Washington Medicaid Beneficiaries.
Meisel ZF; Lupulescu-Mann N; Charlesworth CJ; Kim H; Sun BC
Ann Emerg Med; 2019 Nov; 74(5):611-621. PubMed ID: 31229392
[TBL] [Abstract][Full Text] [Related]
38. Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study.
Shah N; Bhor M; Xie L; Halloway R; Arcona S; Paulose J; Yuce H
Health Qual Life Outcomes; 2019 Oct; 17(1):155. PubMed ID: 31619251
[TBL] [Abstract][Full Text] [Related]
39. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
Peterson EE; Salemi JL; Dongarwar D; Salihu HM
Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
[TBL] [Abstract][Full Text] [Related]
40. Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.
Genao L; Durheim MT; Mi X; Todd JL; Whitson HE; Curtis LH
Ann Am Thorac Soc; 2015 Dec; 12(12):1805-12. PubMed ID: 26394180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
